l-carnitine supplement for fat loss (500mg) L-CARNITINE

If something works or doesnt the design makes it hard to say which compound was responsible

Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP1 and amylin analogues owenhaskins Dec 19, 2025 2 min read Novo Nordisk has submitted a New Drug Application (NDA) to the FDA for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition

Antiobesity effect of garlic extract fermented by Lactobacillus plantarum BL2 in diet-induced obese mice

doi: 10.1016/0006-8993(93)90770-N 116 SousaS